Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Hematology/Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- WHO classification of tumours of soft tissue and bone.4th edition. IARC Press, Lyon (France)2013
- Chapter 1 - Epidemiology of primary bone tumors and economical aspects of bone metastases.in: Heymann D. Bone cancer. 2nd edition. Academic Press, San Diego (CA)2015: 5-10
- Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.Cancer. 2009; 115: 1531-1543
- Bone sarcoma: MD Anderson cancer care series.Springer, New York2012
- Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969-2016).(Available at:) (Accessed April 14, 2019)
- Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years.Cancer. 1986; 57: 1442-1449
- Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?.Eur J Cancer. 2011; 47: 2431-2445
- Hematogenous micrometastases in osteosarcoma patients.Clin Cancer Res. 2005; 11: 4666-4673
- EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.Ann Oncol. 2015; 26: 407-414
- Risk factors for local recurrences after limb-salvage surgery for high-grade osteosarcoma of the extremities.Ann Oncol. 1997; 8: 899-903
- Pathologic fracture in osteosarcoma : prognostic importance and treatment implications.J Bone Joint Surg Am. 2002; 84-a: 49-57
- Prognostic factors and outcomes for osteosarcoma: an international collaboration.Eur J Cancer. 2009; 45: 2367-2375
- Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group.J Clin Oncol. 2003; 21: 334-341
- Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group.Cancer. 2002; 94: 1069-1077
- Osteosarcoma of the head and neck: meta-analysis of nonrandomized studies.Laryngoscope. 1997; 107: 56-61
- Osteosarcoma. An assessment of management with particular reference to primary irradiation and selective delayed amputation.Cancer. 1972; 30: 393-400
- The role of radiation therapy in the treatment of osteosarcoma.Radiology. 1976; 120: 163-165
- Osteogenic sarcoma; a study based on 133 patients.J R Coll Surg Edinb. 1955; 1: 79-111
- A study of the response of osteogenic sarcoma and adjacent normal tissues to radiation.Int J Radiat Oncol Biol Phys. 1981; 7: 593-595
- Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?.Cancer. 2002; 95: 2202-2210
- Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma.Cancer. 2011; 117: 4522-4530
- Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk.Cancer. 2012; 118: 4555-4563
- Alpha emitter radium-223 and survival in metastatic prostate cancer.N Engl J Med. 2013; 369: 213-223
- Radium-223 in the treatment of osteoblastic metastases: a critical clinical review.Int J Radiat Oncol Biol Phys. 2015; 91: 898-906
- Alpha particle Radium 223 dichloride in high-risk osteosarcoma: a phase I dose escalation trial.Clin Cancer Res. 2019; 25: 3802-3810
- Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. I. The intramedullary cartilage tumors.Skeletal Radiol. 1997; 26: 325-353
- Secondary chondrosarcoma in cartilage bone tumors: report of 32 patients.J Orthop Sci. 2007; 12: 415-423
- IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.J Pathol. 2011; 224: 334-343
- Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets.Sarcoma. 2010; 2011: 381564
- Intrinsic radiation resistance in human chondrosarcoma cells.Biochem Biophys Res Commun. 2006; 346: 379-385
- Radiotherapy of chondrosarcoma of bone.Cancer. 1980; 45: 2769-2777
- Fifteen year radiotherapy experience with chondrosarcoma of bone.Int J Radiat Oncol Biol Phys. 1982; 8: 187-190
- Chordomas and chondrosarcomas-The role of radiation therapy.J Surg Oncol. 2016; 114: 564-569
- Proton therapy for tumors of the skull base.Strahlenther Onkol. 1999; 175: 57-63
- High control rate in patients with chondrosarcoma of the skull base after carbon ion therapy: first report of long-term results.Cancer. 2014; 120: 1579-1585
- Fractionated proton radiation therapy of chordoma and low-grade chondrosarcoma of the base of the skull.J Neurosurg. 1989; 70: 13-17
- Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning.Int J Radiat Oncol Biol Phys. 1995; 31: 467-476
- Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dose postoperative irradiation in the treatment of tumors involving the bone.Int J Radiat Oncol Biol Phys. 2009; 73: 259-266
- Diagnosis and treatment of chordoma.J Natl Compr Canc Netw. 2013; 11: 726-731
- Clinical and pathologic review of 48 cases of chordoma.Cancer. 1985; 56: 182-187
- Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.Am J Surg Pathol. 1992; 16: 1144-1152
- Chordoma: long-term follow-up after radical photon irradiation.Radiother Oncol. 1996; 41: 67-72
- Systemic therapy options for unresectable and metastatic chordomas.Curr Oncol Rep. 2011; 13: 323-330
- Sacral chordoma: can local recurrence after sacrectomy be predicted?.Clin Orthop Relat Res. 2008; 466: 2217-2223
- Chordoma. Thirty-five-year study at Memorial Hospital.Cancer. 1967; 20: 1841-1850
- Chordoma: the results of megavoltage radiation therapy.Int J Radiat Oncol Biol Phys. 1983; 9: 633-642
- Retrospective long-term follow-up analysis in 21 patients with chordomas of various sites treated at a single institution.J Neurosurg. 1991; 75: 374-377
- Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas.Int J Radiat Oncol Biol Phys. 2009; 74: 732-739
- Updated outcome and analysis of tumor response in mobile spine and sacral chordoma treated with definitive high-dose photon/proton radiation therapy.Int J Radiat Oncol Biol Phys. 2017; 97: 254-262
- New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.J Natl Cancer Inst. 2000; 92: 205-216
- Phase II study of imatinib in advanced chordoma.J Clin Oncol. 2012; 30: 914-920
- Immunotherapy as a potential treatment for chordoma: a review.Curr Oncol Rep. 2016; 18: 55
- Medical treatment of advanced chordomas.Eur J Cancer. 2017; 83: 220-228
- Chordoma: the quest for better treatment options.Oncol Ther. 2016; 4: 35-51
- The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population.Am J Clin Pathol. 1982; 77: 665-673
- Enzinger and Weiss’s soft tissue tumors, 6th edition.Adv Anat Pathol. 2014; 21: 216
- Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought.Ann Surg Oncol. 2013; 20: 4096-4102
- Toward observation as first-line management in abdominal desmoid tumors.Ann Surg Oncol. 2016; 23: 2212-2219
- Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy.J Clin Oncol. 1999; 17: 158-167
- Chest-wall desmoid tumors: results of surgical intervention.Ann Thorac Surg. 2004; 78 ([discussion: 1219–23]): 1219-1223
- Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy.Br J Surg. 1995; 82: 510-514
- Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles.Cancer. 2000; 88: 1517-1523
- Radiation therapy in the management of desmoid tumors.Int J Radiat Oncol Biol Phys. 1998; 42: 1007-1014
- The management of desmoid tumors.Int J Radiat Oncol Biol Phys. 1993; 26: 851-858
- External beam radiotherapy for primary and adjuvant management of aggressive fibromatosis.Int J Radiat Oncol Biol Phys. 2002; 54: 177-181
- Individualizing management of aggressive fibromatoses.Int J Radiat Oncol Biol Phys. 1998; 40: 637-645
- The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors.Int J Radiat Oncol Biol Phys. 1997; 39: 659-665
- Treatment of recurrent desmoid tumour with tamoxifen.Aust N Z J Surg. 1990; 60: 919-921
- Endocrine therapy for desmoid tumors.Cancer. 1991; 68: 1384-1388
- Tamoxifen for the treatment of malignancies other than breast and endometrial carcinoma.Semin Oncol. 1997; 24: S1-65-S1-70
- Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis.Dis Colon Rectum. 1992; 35: 29-33
- Regression of large pelvic desmoid tumor by tamoxifen and sulindac.Urology. 1996; 47: 756-759
- Sequential treatment of recurrent mesenteric desmoid tumor.Cancer. 1996; 77: 1061-1065
- Desmoids in familial adenomatous polyposis.Br J Surg. 1996; 83: 1494-1504
- Noncytotoxic drug therapy in children with unresectable desmoid tumors.Cancer. 1997; 80: 334-340
- High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors.Cancer. 2004; 100: 612-620
- Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.Cancer. 2001; 92: 1259-1264
- Sporadic desmoid tumors in the pediatric population: a single center experience and review of the literature.J Pediatr Surg. 2017; 52: 1637-1641
- Sorafenib for advanced and refractory desmoid tumors.N Engl J Med. 2018; 379: 2417-2428
Article info
Publication history
Published online: October 28, 2019
Footnotes
Disclosure: The authors have nothing to disclose.
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
